VaxigripTetra NH/VaxigripTetra SH Description

VaxigripTetra NH: Influenza virus (inactivated, split) of the following strains*: A/Victoria/2570/2019 (H1N1) pdm09 - like virus (A/Victoria/2570/2019, IVR- 215) 15 micrograms HA**.
A/Darwin/9/2021 (H3N2)-like virus (A/Darwin/9/2021, IVR-228) 15 micrograms HA**.
B/Austria/1359417/2021-like virus (B/Michigan/01/2021, wild type) 15 micrograms HA**.
B/Phuket/3073/2013 - like virus (B/Phuket/3073/2013, wild type) 15 micrograms HA**.
For one 0.5 mL dose.
* propagated in fertilised hens' eggs from healthy chicken flocks.
** haemagglutinin.
This vaccine complies with the WHO recommendations (Northern Hemisphere) and EU decision for the 2022/2023 season.
VaxigripTetra NH may contain traces of eggs, such as ovalbumin, and of neomycin, formaldehyde and octoxinol-9, which are used during the manufacturing process (see Contraindications).
VaxigripTetra SH: Influenza virus (inactivated, split) of the following strains*: A/Sydney/5/2021 (H1N1) pdm09-like virus (A/Sydney/5/2021, SAN-013) 15 micrograms HA**.
A/Darwin/9/2021 (H3N2)-like virus (A/Darwin/9/2021, IVR-228) 15 micrograms HA**.
B/Austria/1359417/2021-like virus (B/Michigan/01/2021, wild type) 15 micrograms HA**.
B/Phuket/3073/2013 - like virus (B/Phuket/3073/2013, wild type) 15 micrograms HA**.
For one 0.5 mL dose.
* propagated in fertilised hens' eggs from healthy chicken flocks.
** haemagglutinin.
This vaccine complies with the WHO recommendations (Southern Hemisphere) for the 2023 season.
VaxigripTetra SH may contain traces of eggs, such as ovalbumin, and of neomycin, formaldehyde and octoxinol-9, which are used during the manufacturing process (see Contraindications).
Excipients/Inactive Ingredients: Buffer Solution: Sodium chloride, Potassium chloride, Disodium phosphate dihydrate, Potassium dihydrogen phosphate, Water for injections.